✦ LIBER ✦

Prevalence and incidence of hepatitis B virus, hepatitis C virus and human immunodeficiency virus among personnel and patients of a psychiatric hospital

✍ Scribed by Vincenzo Di Nardo; Nicola Petrosillo; Giuseppe Ippolito; Maria Elena Bonaventura; Vincenzo Puro; Bruno Chiaretti; Mauro Tosoni

Publisher: Springer
Year: 1995
Tongue: English
Weight: 452 KB
Volume: 11
Category: Article
ISSN: 0393-2990
DOI: 10.1007/bf01719496

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevalence of hepatitis C virus antibodi

Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus

✍ Paul H. Hayashi; Neil Flynn; Stephen A. McCurdy; I. K. Kuramoto; Paul V. Holland 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB 👁 2 views

## Abstract A study was undertaken to determine the prevalence and risk factors for serological evidence of hepatitis C virus (HCV) infection in patients infected with the human immunodeficiency virus (HIV). Tests for anti‐HCV antibody were carried out by enzyme‐linked immunoassay (EIA) on 101 HIV‐

Prevalence and genotypes of GB virus C/h

Prevalence and genotypes of GB virus C/hepatitis G virus (GBV-C/HGV) and hepatitis C virus among patients infected with human immunodeficiency virus: Evidence of GBV-C/HGV sexual transmission

✍ Ibáñez, Angela; Giménez-Barcons, Mireia; Tajahuerce, Angel; Tural, Cristina; Sir 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

The development of new antiretroviral agents may improve survival of HIV-infected individuals, and therefore chronic viral hepatitis may become more relevant in these patients. The presence of GBV-C/HGV and hepatitis C virus (HCV) RNA were investigated by reverse transcriptasenested polymerase chain

Interactions between human immunodeficie

Interactions between human immunodeficiency virus-1, hepatitis delta virus and hepatitis B virus infections in 260 chronic carriers of hepatitis B virus

✍ Chantal Housset; Stanislas Pol; Françoise Carnot; Frédéric Dubois; Bertrand Nalp 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 720 KB

To evaluate the factors determining the severity of chronic hepatitis B virus infection and the interactions of human immunodeficiency virus and hepatitis delta virus infections, we retrospectively analyzed 260 patients, 146 of whom were followed for a mean of 31.4 c 1.8 mo. Human immunodeficiency v

Hepatitis B virus genotype G: Prevalence

Hepatitis B virus genotype G: Prevalence and impact in patients co-infected with human immunodeficiency virus

✍ Doan Y. Dao; Jody Balko; Nahid Attar; Enayet Neak; He-Jun Yuan; William M. Lee; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

## Abstract Relatively little is known about the role of hepatitis B virus (HBV) genotype G (HBV/G) in patients co‐infected with human immunodeficiency virus (HIV) and HBV. This study examined the prevalence and association of HBV/G to liver fibrosis in co‐infected patients. HBV genotypes were dete

High prevalence of GB virus C/hepatitis

High prevalence of GB virus C/hepatitis G virus RNA in patients infected with human immunodeficiency virus

✍ Rey, D.; Fraize, S.; Vidinic, J.; Meyer, P.; Fritsch, S.; Labouret, N.; Schmitt, 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 2 views

Prevalence of GBV-C/HGV was determined in a cohort of HIV-infected patients, via a reverse transcription-polymerase chain reaction detection of RNA in serum, amplifying the NS5 region of GBV-C/HGV genome. GBV-C/HGV RNA was detected in 143 (37.7%) of 379 patients, with similar results in the differen

Seroepidemiology of hepatitis b virus, h

Seroepidemiology of hepatitis b virus, hepatitis d virus, and human immunodeficiency virus infections among parenteral drug abusers in southern taiwan

✍ Dye-Chii Chung; Dr. Ying-Chin Ko; Chien-Jen Chen; Eng-Rin Chen; Chung-Chieng Wu; 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB

A total of 390 parenteral drug abusers (PDAs) at the Kaohsiung Municipal Narcotics Abstention Institute were examined for markers of hepatitis B virus (HBV), hepatitis D virus (HDV), and human immunodeficiency virus (HIV). All sera were tested for hepatitis B surface antigen (HBsAg), surface antibod